Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2011-09-02

Clinical Trial Update: To Determine Tolerability and Efficacy of Long-term Oral Lacosamide in Patients With Partial Seizures [Phase 2]

View source ↗

Summary

A Phase 2 study evaluated the tolerability and efficacy of long-term oral lacosamide in patients with partial seizures; results were posted after completion of …

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Vimpat (lacosamide)

Snippet

Sponsor: UCB Pharma | Conditions: Partial Epilepsies | Phase 2 | Status: COMPLETED | Results posted: 2011-09-02